Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami Publisher Pubmed



Sharbatdar Y1 ; Mousavian R2 ; Noorbakhsh Varnosfaderani SM3 ; Aziziyan F4, 5 ; Liaghat M5, 6 ; Baziyar P7 ; Yousefi Rad A8 ; Tavakol C9 ; Moeini AM10 ; Nabiafjadi M4 ; Zalpoor H5, 11 ; Kazemilomedasht F12
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anesthesiology, School of Allied Medical Sciences, Ahvaz Jundishapur, University of Medical Sciences, Ahvaz, Iran
  2. 2. Department of Clinical Biochemistry, School of Medicine, Cellular and Molecular Research Center, Medical Basic Science Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  3. 3. Department of Radiology, Afzalipour Hospital, Kerman University of Medical Science, Kerman, Iran
  4. 4. Department of Biochemistry, Faculty of Biological Sciences, University of Tarbiat Modares, Tehran, Iran
  5. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  6. 6. Department of Medical Laboratory Sciences, Faculty of Medical Sciences, Islamic Azad University, Kazerun Branch, Kazerun, Iran
  7. 7. Department of Molecular and Cell Biology, Faculty of Basic Science, University of Mazandaran, Babolsar, Iran
  8. 8. Department of Biochemistry, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
  9. 9. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Department of Internal Medicine, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
  11. 11. Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  12. 12. Venom and Biotherapeutics Molecules Laboratory, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Source: Inflammopharmacology Published:2023


Abstract

According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is caused by a SARS-CoV-2 infection. In this regard, COVID-19 may make diabetic patients more sensitive to hyperglycemia by modifying the immunological and inflammatory responses and increasing reactive oxygen species (ROS) predisposing the patients to severe COVID-19 and potentially lethal results. Actually, in addition to COVID-19, diabetic patients have been demonstrated to have abnormally high levels of inflammatory cytokines, increased virus entrance, and decreased immune response. On the other hand, during the severe stage of COVID-19, the SARS-CoV-2-infected patients have lymphopenia and inflammatory cytokine storms that cause damage to several body organs such as β cells of the pancreas which may make them as future diabetic candidates. In this line, the nuclear factor kappa B (NF-κB) pathway, which is activated by a number of mediators, plays a substantial part in cytokine storms through various pathways. In this pathway, some polymorphisms also make the individuals more competent to diabetes via infection with SARS-CoV-2. On the other hand, during hospitalization of SARS-CoV-2-infected patients, the use of some drugs may unintentionally lead to diabetes in the future via increasing inflammation and stress oxidative. Thus, in this review, we will first explain why diabetic patients are more susceptible to COVID-19. Second, we will warn about a future global diabetes tsunami via the SARS-CoV-2 as one of its long-term complications. © 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Other Related Docs
10. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
15. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
18. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
23. The Prognostic Significance of Insulin Resistance in Covid-19: A Review, Journal of Diabetes and Metabolic Disorders (2024)
38. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
43. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
48. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)